David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$397M |
| 2 |
YHOO
Yahoo Inc
YHOO
|
+$342M |
| 3 |
Bank of America
BAC
|
+$322M |
| 4 |
Citigroup
C
|
+$260M |
| 5 |
Booking.com
BKNG
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$637M |
| 2 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$397M |
| 3 |
Gilead Sciences
GILD
|
+$358M |
| 4 |
Phillips 66
PSX
|
+$330M |
| 5 |
Apple
AAPL
|
+$320M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.78% |
| 2 | Technology | 11.11% |
| 3 | Financials | 10% |
| 4 | Consumer Discretionary | 8.83% |
| 5 | Communication Services | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2876
Marriott International
MAR
$93.3B
| $391K | ﹤0.01% |
5,496
+442
| +9% | +$28.9K |
|
|
PCO
2877
DELISTED
Pendrell Corporation - Class A
PCO
| $390K | ﹤0.01% |
735
-23
| -3% | -$12.4K |
|
2878
Eaton
ETN
$159B
| $389K | ﹤0.01% |
6,215
-484,981
| -99% | -$26.8M |
|
2879
Skyworks Solutions
SWKS
$9.89B
| $388K | ﹤0.01% |
4,978
-32,791
| -87% | -$2.22M |
|
|
PTLA
2880
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $388K | ﹤0.01% |
19,039
-45,104
| -70% | -$1.43M |
|
|
SSRI
2881
DELISTED
Silver Standard Resources
SSRI
| $388K | ﹤0.01% |
+69,900
| New | +$369K |
|
2882
Ralph Lauren
RL
$21.6B
| $385K | ﹤0.01% |
3,996
-22,350
| -85% | -$2.19M |
|
|
ATRI
2883
DELISTED
Atrion Corp
ATRI
| $383K | ﹤0.01% |
968
| – | – |
|
|
ADXS
2884
DELISTED
Advaxis Inc
ADXS
| $383K | ﹤0.01% |
+2,825
| New | +$313K |
|
|
AMBR
2885
DELISTED
Amber Road Inc
AMBR
| $382K | ﹤0.01% |
70,599
+1,123
| +2% | +$5.19K |
|
|
KE
2886
Kimball Electronics
KE
$565M
| $381K | ﹤0.01% |
34,082
+10,965
| +47% | +$118K |
|
2887
Whirlpool
WHR
$2.65B
| $379K | ﹤0.01% |
2,100
-4,755
| -69% | -$709K |
|
|
WLH
2888
DELISTED
WILLIAM LYON HOMES
WLH
| $379K | ﹤0.01% |
26,159
-44,712
| -63% | -$529K |
|
|
JWN
2889
PUT
DELISTED
Nordstrom
JWN
| $378K | ﹤0.01% |
+6,600
| New | +$340K |
|
2890
Travere Therapeutics
TVTX
$6.32B
| $377K | ﹤0.01% |
+27,609
| New | +$419K |
|
|
HWCC
2891
DELISTED
Houston Wire & Cable Company
HWCC
| $377K | ﹤0.01% |
53,979
-12,249
| -18% | -$71K |
|
|
GES
2892
PUT
DELISTED
Guess Inc
GES
| $375K | ﹤0.01% |
20,000
-30,000
| -60% | -$577K |
|
|
SASR
2893
DELISTED
Sandy Spring Bancorp Inc
SASR
| $375K | ﹤0.01% |
13,491
+5,419
| +67% | +$143K |
|
2894
Vanda Pharmaceuticals
VNDA
$329M
| $372K | ﹤0.01% |
44,512
+28,215
| +173% | +$232K |
|
2895
PUT
DXP Enterprises
DXPE
$2.92B
| $371K | ﹤0.01% |
+21,100
| New | +$346K |
|
|
HTB
2896
HomeTrust Bancshares
HTB
$771M
| $371K | ﹤0.01% |
20,223
-4,293
| -18% | -$78.5K |
|
|
CPLA
2897
DELISTED
Capella Education Company
CPLA
| $371K | ﹤0.01% |
+7,053
| New | +$326K |
|
|
SF
2898
CALL
Stifel
SF
$12B
| $370K | ﹤0.01% |
+28,125
| New | +$400K |
|
2899
Deutsche Bank
DB
$73.4B
| $369K | ﹤0.01% |
+24,392
| New | +$408K |
|
|
MXIM
2900
CALL
DELISTED
Maxim Integrated Products
MXIM
| $368K | ﹤0.01% |
10,000
-16,500
| -62% | -$554K |
|
Similar funds
David Shaw's Q1 2016 Portfolio in Review
As of Q1 2016, David Shaw held 4,137 positions worth $55.7B, down 17% from $67.2B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
David Shaw withdrew a net $9.72B in Q1 2016, closing 773 positions and reducing 1,495 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $637M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
Against the trend, David Shaw opened a new position in EQT Corp worth $47.6M.
- David Shaw's largest Q1 2016 buy was EQT Corp: 1,300,361 shares worth $47.6M.
- David Shaw added most to Allergan plc in Q1 2016, an estimated $397M increase.
- David Shaw's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $358M.
- David Shaw fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $637M.
- David Shaw's ten largest holdings make up 9.5% of its $55.7B portfolio in Q1 2016.
- David Shaw opened 382 new positions and closed 773 in Q1 2016.
- David Shaw's portfolio value fell 17% quarter-over-quarter to $55.7B.
Based on D.E. Shaw & Co's 13F filing for Q1 2016, filed 16 May 2016.